SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer
Clinical trial NCT06422156 · UNKNOWN
Trial details
- NCT number
- NCT06422156
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.